Form D · Biotechnology
OXYBAND TECHNOLOGIES INC
Woodbury, MN · CIK 0001373969
Offering snapshot reported Mar 23, 2010 · SEC filing
- Reported sold
- $700K Offering amount: $11.8M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $24.3K Reported outside-investor minimum
- First sale
- Mar 18, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2010 | Initial | $699,999 | No comparison | 2 | SEC filing |
| Aug 23, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-94186
404,040 Series A-1 Preferred Shares at $6.93/share; and Option to buy 1,298,702 Series A-1 Preferred Shares at &6.93/share.
Source: Form D, filed Mar 23, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Casillas | Director |
| Amie Franklin | Director, Executive, Promoter |
| William Logue | Director |
| Stan Poulos | Director |
| Alexis Walker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7616 Currell Boulevard, Suite 249
Woodbury, MN, 55125
Woodbury, MN, 55125